US EditionMedtronic Announces First Commercial Use of Liberant Thrombectomy System
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Medtronic announces first commercial use of Liberant thrombectomy system
Medtronic has announced the first commercial use of its Liberant thrombectomy system, which is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems. Medtronic notes that Liberant expands the company’s portfolio of treatment options for peripheral arterial and venous diseases to include mechanical aspiration thrombectomy. The first procedure using the Liberant thrombectomy syste…
Medtronic’s Liberant Thrombectomy System Used in First Commercial Case
December 10, 2025—Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems. The first procedure using the Liberant thrombectomy system was performed on November 21 by vascular surgeon Ajit Rao, MD, at The Mount Sinai Hospital in New York. “The Liberant thrombectomy system is an effective new …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
